The effects of intravenous metoclopramide (Maxolon) on the lower oesophageal sphincter (LOS) were studied in three groups of patients, one group being normal control and the other two being pregnant females, one without heartburn and the other with.
A zone of increased intraluminal pressure exists at the gastro-oesophageal junction in man which is alleged to act as a physiological sphincter.
Contraction of this lower oesophageal sphincter (L.OS) under normal circumstances prevents reflux of acid gastric content (Cohen and Lipshutz 1971) .
Heartburn is a common and frequent distressing symptom of pregnancy (Donald 1964) , the etiology of which is uncertain. It is, however, known to be associated with a weak LOS, and gastro-oesophageal reflux (Lind et al. 1968) .
A steady decrease in maternal mortality due to advances in obstetrical care has occurred during the last decade, whilst deaths due to anaesthetic causes, in particular aspiration of vomitus, have increased over the same period (Arthure et al. 1969) . Regurgitation and pulmonary aspiration of acid gastric content gives rise to chemical pneumonitis and pulmonary oedema, a syndrome first described by Mendelson in 1946 (Mendelson 1946 .
We have previously demonstrated in fasting healthy pregnant and non-pregnant volunteers, that intravenous atropine 0·6 mg decreases the intraluminal pressure of the LOS (Dow et al. 1977 ; this might increase the risk of pulmonary aspiration in patients requiring general anaesthesia. Reversal of this effect by metoclopramide (Brockut ne et al. 1976 ) might enhance the patient's safety, and prove a useful addition to the anaesthetist's armamentarium. This paper concerns our investigations into the effects of metoclopramide on the LOS in normal and pregnant subjects.
SUBJECTS AND METHODS
Three groups of women were studied, all of whom gave their informed consent. The first group of 8 non-pregnant subjects, ranging in age from 17 to 46 years, mean age of 31· 8 (SEM 1'6), acted as controls.
The second group consisted of 10 normal pregnant women, without heartburn, aged between 17 and 36 years, mean age of 25·8 (SEM 1'9).
The third group comprised 10 pregnant women aged between 19 and 38 years, mean age 30·5 (SEM 1, 9) , all of whom complained of heartburn during their current pregnancy.
Patients with a history of upper gastrointestinal surgery or disease, with exception of heartburn, were excluded from the study.
The three groups were comparable in regard to parity and age. All pregnant patients were between 36-40 weeks gestation.
METHODS
Each group received metoclopramide 10 mg intravenously after control values of gastrooesophageal junction pressures, and pH had been measured. The method of motility study and the measurement of reflux have been previously described .
The gastric pressure (G.P.), the LOS pressure (S.P.) and the oesophageal pressure (O.P.) were calculated in each subject. The difference recorded between GP and SP was termed the barrier pressure (B.P.).
Respiration was monitored throughout using a tubular pneumograph placed around the subject's chest, connected to the Dynograph amplifier and recorder system.
MEASUREMENT OF REFLUX
Tests for reflux were performed after completion of the pressure measurements. A Beckman intestinal pH electrode No. 39042 was placed 5 cm above the LOS. The patient was instructed to cough, and then to perform Valsalva manoeuvres, with and without straight leg raising as a means of stressing the sphincter.
Reflux was graded as follows :-Positive-If the pH in the oesophagus dropped more than one pH unit during a stress test (stress reflux).
Free reflux-defined as a failure of the pH to rise above 3 ·5 at any time. Negative-if neither stress nor free reflux was seen. Statistical analysis was performed using Student's tests for paired and unpaired data.
RESULTS
The mean intraluminal pressures obtained in all patients are shown in Table 1 .
CONTROL GROUP
Under resting conditions the mean pressure in the stomach, LOS and oesophagus, were 29'7, 51·8 and 8·7 cm HP giving a mean barrier pressure of 22·1 cm H 2 0. After the administration of metoclopramide, there was a significant increase in the lower oesophageal pressure of 21·4 cm H 2 0 (p<0'005) and also in the barrier pressure of 20 . 5 cm H 2 0 (p < 0 . 001). The mean oesophageal pressure did not change after metoclopramide. Pregnant group (10 asymptomatic patients and 10 patients with heartburn).
Under basal conditions there was no significant difference in the gastric pressures between the two groups. The barrier pressures were significantly higher in the asymptomatic group (p<O '02) compared to the heartburn group.
After the administration of metoclopramide no change occurred in the gastric pressure. However, a rise in the LOS pressure of 13·8 cm H 2 0 was noted in the asymptomatic group and of 8·9 cm H 2 0 in the heartburn group (p<0·005 and p<0'05 respectively). Barrier pressure increased in both groups, although more significantly in the asymptomatic patients-15·2 and 10·2 cms H 2 0 (p<O'OOl and p<0·005 respectively ( Figure 1 ). No change in oesophageal pressure was observed. J. G. BROCK-UTNR ET AL.
COMPARISON OF CONTROL AND PREGNANT GROUPS
In the basal condition and after metoclopramide, gastric pressures were significantly higher in the pregnant patients (p<O·OOl). After metoclopramide both the non-pregnant control and the asymptomatic pregnant patients had a significantly higher barrier pressure than the heartburn group (both p < 0 ·005). 
REFLUX
No significant difference was found in the stomach or oesophageal pH of the three groups of patients before and after metoclopramide. Furthermore, no change in the oesophageal pH was noted between the groups.
Stress test for reflux was negative in all patients in the control group before and after metoclopramide. The test was positive in one case in each of the pregnant groups both before and after metoclopramide.
Free reflux was present in one patient 111 the asymptomatic group before and after meto-c10pramide and in the group of patients with heartburn 3 patients had free reflux before metoclopramide and only one patient had free reflux after metoc1opramide. The latter finding just failed to reach statistical significance using the Fischer Exact probability test.
DISCUSSION
The present study confirms previous observations (Lind et al. 1968 , Dow et al. 1977 ) that an increase in intragastric pressure occurs in pregnancy possibly due to the presence of the enlarging uterus as pregnancy advances.
In the pregnant patients without heartburn, the LOS pressure rose in response to raised gastric pressure as we have previously shown (Dow et al. 1977) , thus maintaining a barrier pressure similar to that found in a non-pregnant patient. However, in the heartburn group, the resting LOS pressure remained at a lower level, when compared to the non-pregnant patients, and asymptomatic pregnant patients, indicating a "weak" sphincter. The lower barrier pressure noted in patients with heartburn may indicate that either the LOS response to raised intragastric pressure is altered or that decompensation has occurred during the course of pregnancy. The reason for such a difference in response seems speculative; endogenous gastrin has been implicated, but not shown to effect the LOS tone as does pentagastrin; nor have plasma gastrin levels been found to be lower in patients with heartburn (Cohen and Lipshutz 1971) . The increase in the LOS pressure which was found after metoc1opramide in all groups was least in the heartburn pregnant subjects. The incidence of reflux, as judged by the stress test and free reflux was greater in the pregnant groups. The significant increase in barrier pressure and the improvement in the free reflux status in the heartburn group, confirms the beneficial effect that this drug has on the competence of the LOS.
The mechanism of action of metoclopramide on the LOS remains to be elucidated. In vitro experiments with human smooth muscle suggests that metoclopramide blocks the adrenergic inhibitory impulses to acetylcholine (Birtley and Baines 1973) . This present study confirms that metoclopramide increases the tone of the LOS man. We have previously shown, in nonpregnant controls, that metoclopramide can be used to reverse the relaxant effects of atropine on the LOS (Brock-utne et al. 1976) . At present we are studying this effect in pregnant patients.
Increasing the resting tone within the LOS is currently believed to be the best method of preventing gastro-oesophageal reflux. Hence metoclopramide should be the drug of choice in preventing gastro-oesophageal reflux in patients at risk, as it not only increases LOS tone (Brockutne et al. 1976 ) but also acts as a potent anti- Anaesthesia and Intensive Care, Vol. VI, No. 1, February, 1978 emetic (Handley 1967) and speeds gastric emptying (Howard and Sharp 1973) . Metoclopramide is relatively free from undesirable side effects in adults (J ames and Hume 1968) although extrapyramidal symptoms have been described in psychiatric patients following very high doses (Borenstein and Bles 1965) . Dystonic reactions such as torticolis, oculogyric crises and trismus have also been observed in children receiving this drug. Metoclopramide appears to be unassociated with serious cardiac dysrhythmias although one case of multifocal ventricular extrasystoles following a single intramuscular injection of 10 mg, has been reported (Shaklai et al. 1974) . None of the patients in this study suffered any side effect of note.
This study demonstrates that metaclopramide increases the LOS tone. Thus the drug may help reduce the incidence of regurgitation of gastric content in patients undergoing elective or emergency obstetrical anaesthesia.
